What's Happening?
10x Genomics has introduced Atera, a new spatial biology platform designed to provide whole-transcriptome spatial analysis with single-cell sensitivity. This platform aims to overcome previous limitations
in spatial technologies, such as trade-offs between scale, sensitivity, and gene selection. Atera enables large-scale studies across various tissue types, supporting both discovery and translational research. The platform was unveiled at the AACR Annual Meeting 2026, showcasing its potential to transform spatial biology by allowing comprehensive measurement of biological systems in their native context.
Why It's Important?
The introduction of Atera represents a significant advancement in spatial biology, offering researchers the ability to conduct high-resolution studies that were previously constrained by technological limitations. This development is expected to accelerate research in areas such as oncology and immunology by providing deeper insights into cellular interactions and disease mechanisms. The platform's ability to integrate with existing research infrastructures and its potential to enhance translational research could lead to the discovery of new therapeutic targets and improve understanding of complex diseases.
What's Next?
10x Genomics plans to begin shipping the Atera platform in the second half of 2026. The company is also launching Catalyst Research Services to facilitate access to the platform for researchers, regardless of project size. This initiative aims to broaden the impact of Atera by enabling more researchers to conduct comprehensive spatial studies. Additionally, the platform's integration with a new cloud analysis system will enhance data management and collaboration, further supporting the advancement of spatial biology research.
